10 completed, 2 terminated, 1 withdrawn. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 10, Terminated 2, Withdrawn 1 |
Follow Duotrav: new trials by email Literature Review of Duotrav trials Research Report on Duotrav
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV® Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension, Brinzolamide/brimonidine vehicle, Travoprost 0.004%/timolol 0.5% solution - Open-angle Glaucoma, Ocular Hypertension | Phase 4 | Terminated | Alcon Research | 173 | 2016-06-24 | 2019-05-29 |
| Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma Brimonidine Tartrate, Dorzolamide (as Dorzolamide Hydrochloride) 20 Mg/mL and Timolol (as Timolol Maleate) 5 Mg/mL Eye Drops, Brinzolamide/Timolol 10 MG/1 ML-5 MG/1 ML Ophthalmic Suspension - Glaucoma, Open-Angle | Phase 4 | Completed | Afyon Kocatepe University Hospital | 96 | 2014-01-01 | 2019-05-29 |
| Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure Beta-blocker monotherapy, Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solution - Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Completed | Alcon Research | 157 | 2013-12-01 | 2016-08-08 |
| Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia Travoprost 0.004%/Timolol 0.5% Fixed Combination (DuoTrav) - Glaucoma, Ocular Hypertension | Phase 4 | Withdrawn | Alcon Research | 2013-02-01 | 2013-02-07 | |
| Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy Travoprost/Timolol Maleate BAK-Free Fixed Combination - Glaucoma | Phase 4 | Terminated | Alcon Research | 37 | 2012-06-01 | 2014-12-03 |
| Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction travoprost ophthalmic solution 0.004%, travoprost 0.004% / timolol 0.5% combination ophthalmic solution, Bimatoprost ophthalmic solution 0.01% - Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Completed | Allergan | 135 | 2011-12-01 | 2014-08-15 |
| Efficacy of Changing to DUOTRAV® From Prior Therapy Travoprost 0.004%+Timolol 0.5% ophthalmic solution - Open-Angle Glaucoma, Ocular Hypertension | Phase 4 | Completed | Alcon Research | 60 | 2011-08-01 | 2014-02-10 |
| Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol Travoprost 0.004%/timolol maleate 0.5% fixed combination - Glaucoma | Phase 4 | Completed | Alcon Research | 50 | 2011-02-01 | 2013-07-08 |
| Safety and Efficacy of Changing to DuoTrav From Prior Therapy Travoprost 0.004%/Timolol 0.5% Fixed Combination eye drops solution (Duotrav®) - Glaucoma | Phase 4 | Completed | Alcon Research | 105 | 2010-10-01 | 2016-11-21 |
| DuoTrav® Eye Drops As Replacement Therapy Program DuoTrav - Open-angle Glaucoma, Ocular Hypertension | Phase 4 | Completed | Alcon Research | 128 | 2009-02-01 | 2012-09-20 |
| A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma DuoTrav (travoprost-timolol ophthalmic drops), Xalacom (latanoprost-timolol ophthalmic drops) - Open-Angle Glaucoma, Ocular Hypertension | Phase 4 | Completed | Ophthalmic Consultants Centres, Canada | 54 | 2009-01-01 | 2015-04-21 |
| Adherence Assessment With Travalert Dosing Aid Travoprost 0.004%/timolol 0.5% fixed combination eye drops (DuoTrav), Travoprost 0.004% eye drops, Timolol 0.05% eye drops - Open-angle Glaucoma, Ocular Hypertension | Phase 4 | Completed | Alcon Research | 102 | 2007-10-01 | 2012-07-12 |
| Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav Travoprost 0.004%/timolol maleate 0.5% fixed combination ophthalmic solution (DuoTrav) - Glaucoma | Phase 4 | Completed | Alcon Research | 522 | 2007-08-01 | 2016-11-18 |
Glaucoma, Open-Angle (10) · Ocular Hypertension (10) · Glaucoma (7) · Patient Compliance (1)
Alcon Research (10) · Afyon Kocatepe University Hospital (1) · Allergan (1) · Ophthalmic Consultants Centres, Canada (1)
Canada (2) · Germany (2) · United States (2) · Brazil (1) · China (1) · Spain (1)
Abayomi Ogundele, PharmD (3) · David B Yan, MD (1) · Dr Francisco M. Honrubia (1) · Mark C Jasek (1) · Navroop Gill, OD (1) · Severine Durier, Pharm.D (1)
PMID 11589866, PMID 14736774, PMID 14996520, PMID 17415690, PMID 18826749, PMID 20505839, PMID 21773673, PMID 28239491, PMID 9098273
2016 (1)